Bernie Goes After Big Pharma

[Minimalist]

Go for it.

http://www.rawstory.com/2016/11/bernie-s...weetstorm/

Bernie Sanders sends another Big Pharma giant’s stock plummeting after diabetes drug Tweetstorm

Remember Bernie fans - if the dems retake the senate then Bernie will chair the Budget Committee.   Paul Ryan is already filling his pants with diarrhea over that idea.

[vorlon13]

After the shitty treatment he's received from the DNC, maybe he should lead the charge to reform the party, drain the swamp, and make the outfit something I wouldn't be disgusted to be associated with.

And my apt to get my health insurance coverage reinstated is tomorrow. Wonder how much (more) it's going to cost me and how much less coverage and how much more copay and deductible I'm getting fucked with.

Sorry, but I'm still young enough (barely it seems) that big pharma ain't in line to fuck me yet.

[vorlon13]

And folks wanting to give Paul Ryan diarrhea need to form a line and remain orderly till they are called up for their turn.

[brewer]

Sorry, I had a hard time getting past "Homolog".

Interesting article that provides additional insight. 

http://time.com/money/4462919/prescripti...-too-high/

[SteelCurtain]

His influence is awesome.

I love the drug company's response: "It's complicated. You wouldn't understand guys, but if you did, you' totally get why we raised the price or a completely necessary, life saving insulin drug 450% over inflation in the last 20 years."

[Minimalist]

The answer is "we're a bunch of greedy fucks."

Oddly, I have no trouble understanding that at all.

[Minimalist]

Perhaps if the miserable motherfuckers didn't spend so much money trying to protect their little monopoly they wouldn't have to charge so much?

http://www.waaytv.com/ap/domestic/pharma...ad878.html

Pharma Running Scared, Injects $17M More to Oppose Prop. 61 ($126M Total); Hoover Poll Shows ‘Yes’ Ahead 51% to 24%

Nov 1, 2016--“Pharma campaign against CA ballot measure tops $126M,” screams the headline in an article in Politico’s ‘Prescription Pulse’ (10/31/16) by Sarah Karlin-Smith and Brett Norman, a dollar amount that now breaks the drug industry’s own previous and shameful record—$109M—for most money contributed to one side of a ballot measure in California history. (The campaign on behalf of Propositions #94-97 in 2008 spent a combined $108.3 million, but that covered four different measures.)
In its Politico posting yesterday on Pharma’s latest contributions, Karlin-Smith and Norman reported that the pharmaceutical industry,
“… has amassed a $126 million war chest to fight off the California ballot measure that would require the state to pay no more for drugs than the Veterans Administration pays.

[SteelCurtain]

Telling...

Just like the Energy Companies pouring money into trying to get Prop 1 passed in Florida. Very telling. They worded that law so confusingly, but media actually did it's job down there.

https://ballotpedia.org/Florida_Solar_En...t_1_(2016)

Florida is one of five states that do not allow a property owner to have a third-party installer put solar panels on their roof and sell the power back to them.
The amendment will leave that ban in place, but, if the ban on solar leasing and sales were removed, the language in the amendment could discourage third-party sales. It gives utility companies the right to impose new fees on all solar customers to compensate for the loss of revenue when solar customers don't buy their power, making solar sales and leasing less economical.

[Minimalist]

Hit 'em again, Bernie.  Harder!

http://www.rawstory.com/2016/11/drugmake...ce-fixing/

Drugmakers under fire for possible U.S. price fixing

Possible price fixing?

Two prominent U.S. lawmakers on Thursday called on federal antitrust regulators to probe whether Sanofi SA, Eli Lilly and Co, Merck & Co Inc and Novo Nordisk A/S colluded to set prices for insulin and other diabetes drugs.

The request by U.S. Senator Bernie Sanders and Representative Elijah Cummings follows a similar letter they sent last fall calling for an investigation into 14 drug companies over price increases of generic drugs.

U.S. prosecutors could file the first charges by the end of the year in their subsequent criminal investigation of generic drugmakers over suspected price collusion, Bloomberg reported on Thursday.